ERYTHROMYCIN ETHYLSUCCINATE- erythromycin ethylsuccinate suspension 
AbbVie Inc.

----------

ERYTHROMYCIN
ETHYLSUCCINATE

PRINCIPAL DISPLAY PANEL - 200 mg per 5 mL Bottle Label

NDC 24338-132-13
100 mL For Oral Suspension
(when mixed)

EryPed® 200

ERYTHROMYCIN
ETHYLSUCCINATE FOR
ORAL SUSPENSION, USP

Erythromycin activity

200 mg per 5 mL
when reconstituted

Rx only

arbor®
PHARMACEUTICALS, INC.



PRINCIPAL DISPLAY PANEL - 200 mg per 5 mL Bottle Label

PRINCIPAL DISPLAY PANEL - 400 mg per 5 mL Bottle Label

NDC 24338-130-13
100 mL For Oral Suspension
(when mixed)

EryPed® 400

ERYTHROMYCIN
ETHYLSUCCINATE FOR
ORAL SUSPENSION, USP

Erythromycin activity

400 mg per 5 mL
when reconstituted

Rx only

arbor®
PHARMACEUTICALS, INC.



PRINCIPAL DISPLAY PANEL - 400 mg per 5 mL Bottle Label
ERYTHROMYCIN ETHYLSUCCINATE 
erythromycin ethylsuccinate suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-6302
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Erythromycin Ethylsuccinate (UNII: 1014KSJ86F) (Erythromycin - UNII:63937KV33D) Erythromycin200 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
Caramel (UNII: T9D99G2B1R)  
polysorbate 80 (UNII: 6OZP39ZG8H)  
sodium citrate (UNII: 1Q73Q2JULR)  
sucrose (UNII: C151H8M554)  
xanthan gum (UNII: TTV12P4NEE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-6302-01100 mL in 1 BOTTLE; Type 0: Not a Combination Product07/05/201110/31/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA05020707/05/201110/31/2020
ERYTHROMYCIN ETHYLSUCCINATE 
erythromycin ethylsuccinate suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-6305
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Erythromycin Ethylsuccinate (UNII: 1014KSJ86F) (Erythromycin - UNII:63937KV33D) Erythromycin400 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
Caramel (UNII: T9D99G2B1R)  
polysorbate 80 (UNII: 6OZP39ZG8H)  
sodium citrate (UNII: 1Q73Q2JULR)  
sucrose (UNII: C151H8M554)  
xanthan gum (UNII: TTV12P4NEE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-6305-48100 mL in 1 BOTTLE; Type 0: Not a Combination Product06/14/201210/31/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA05020706/14/201210/31/2020
Labeler - AbbVie Inc. (078458370)

Revised: 12/2017
Document Id: 0611ee0b-fbc8-5542-5220-c1c92fc1c729
Set id: 70b0d0e4-e28e-4493-80bc-66052e9d7480
Version: 13
Effective Time: 20171207
 
AbbVie Inc.